top of page

Dialysis Market Size, Share, Future Analysis, 2026-2034

Writer: jhon smith
jhon smith
39 minutes ago
4 min read

Market Overview

According to fortune business insights, the global dialysis market growth is witnessing steady growth, driven by the increasing prevalence of chronic kidney disease (CKD), end-stage renal disease (ESRD), and other kidney-related disorders. According to Fortune Business Insights, the global dialysis market was valued at USD 103.15 billion in 2025. The market is projected to grow from USD 108.91 billion in 2026 to USD 170.19 billion by 2034, exhibiting a CAGR of 5.7% during the forecast period (2026–2034). North America dominated the global market with a share of 40.41% in 2025.

The rising incidence of diabetes, hypertension, and other chronic conditions has significantly increased the number of patients requiring renal replacement therapies. Growing awareness regarding kidney health, improvements in healthcare infrastructure, and increasing investments in dialysis facilities are further supporting market expansion. Additionally, technological advancements in dialysis equipment and the growing adoption of home-based treatments are creating new growth opportunities.

Major Players Profiled

  • B. Braun SE (Germany)

  • Fresenius Medical Care AG (Germany)

  • Mozarc Medical Holding LLC (U.S.)

  • DaVita Inc. (U.S.)

  • NIPRO (Japan)

  • Asahi Kasei Medical Co., Ltd. (Japan)

  • Diaverum (Sweden)

  • Kimal (U.K.)

  • BD (U.S.)

  • Vantive (U.S.)

  • WEIGAO GROUP (China)

  • BAIN MEDICAL EQUIPMENT (GUANGZHOU) CO., LTD. (China)

Market Segmentation

The dialysis market is segmented by type, dialysis type, end user, and region.

By Type: The market is categorized into products and services. Products are further divided into equipment and consumables. Equipment includes hemodialysis machines and peritoneal dialysis equipment, while consumables comprise dialyzers, dialysate, cyclers, fluids, access products, and others. The services segment held the largest market share in 2025, supported by the growing number of renal care facilities and increasing demand for chronic and acute dialysis services.

By Dialysis Type: The market is classified into hemodialysis and peritoneal dialysis. Hemodialysis dominated the market in 2025 due to its widespread adoption and established treatment infrastructure. However, peritoneal dialysis is projected to grow at a CAGR of 7.6%, driven by increasing demand for convenient, home-based treatment options.

By End User: The market is divided into dialysis centers and hospitals, and home care. Dialysis centers and hospitals accounted for the largest share in 2025. Meanwhile, the home care segment is expected to register a CAGR of 9.3%, supported by technological advancements, patient convenience, and increasing preference for decentralized healthcare services.

Market Drivers and Restraints

The increasing prevalence of chronic kidney diseases is a major factor driving market growth. The growing number of patients with diabetes and hypertension, combined with the rising geriatric population, is increasing the demand for dialysis equipment, consumables, and treatment services. According to data published in 2024 by Nature, approximately 850 million people worldwide were living with kidney disease.

Furthermore, expanding healthcare infrastructure and improved accessibility to dialysis centers are supporting market growth, particularly across emerging economies such as India, China, and Mexico.

However, complications associated with dialysis procedures, including cardiovascular risks, infections, blood pressure fluctuations, and peritonitis, may limit treatment adoption. Inadequate reimbursement policies, high treatment costs, and shortages of trained healthcare professionals also create challenges, particularly in developing countries.

Regional Insights

North America: North America dominated the global market with a valuation of USD 41.68 billion in 2025. The region's leadership is supported by the high prevalence of CKD and ESRD, advanced healthcare infrastructure, favorable reimbursement policies, and strong adoption of renal replacement therapies. The U.S. market is projected to reach USD 40.32 billion in 2026.

Europe: Europe is expected to reach USD 28.21 billion by 2026, supported by its aging population, increasing incidence of kidney disorders, and established renal care infrastructure. The U.K. and Germany markets are projected to reach USD 3.37 billion and USD 5.06 billion, respectively, in 2026.

Asia Pacific: The region is projected to reach USD 24.89 billion in 2026. Growing healthcare investments, government-supported dialysis programs, and improving treatment accessibility are contributing to regional expansion. Japan, China, and India are forecast to reach USD 5.35 billion, USD 7.05 billion, and USD 2.56 billion, respectively, in 2026.

Latin America and Middle East & Africa: Latin America is projected to reach USD 6.45 billion in 2026, supported by increasing dialysis adoption and the rising incidence of kidney diseases in Brazil. Meanwhile, the Middle East & Africa market is expected to expand through healthcare infrastructure development, strategic partnerships, and growing availability of renal treatment services.

Future Growth Trends

The shift from in-center dialysis toward home-based treatment is emerging as a significant market trend. Increasing adoption of home hemodialysis machines, automated peritoneal dialysis equipment, remote patient monitoring, and connected healthcare platforms is transforming renal care delivery. Additionally, technological innovations, improved treatment accessibility, and investments in emerging economies are expected to create substantial growth opportunities.

Competitive Landscape and Key Industry Developments

Leading companies are focusing on product innovation, strategic collaborations, regulatory approvals, and geographical expansion to strengthen their market positions.

  • September 2025: Mozarc Medical partnered with DK Medical Technology (Suzhou) Co., Ltd. to strengthen PTA balloon technology in the U.S. vascular access market.

  • July 2025: Fresenius SE & Co. KGaA's CRO Frenova announced a genomics collaboration with Nephronomics and GENEWIZ by Azenta Life Sciences to advance precision kidney disease care.

  • June 2025: Fresenius SE & Co. KGaA announced broader U.S. commercialization of its 5008X CAREsystem, supporting the rollout of high-volume hemodiafiltration across its U.S. clinic network.

  • October 2023: Northeast Georgia Health Ventures and Dialyze Direct entered a strategic collaboration to provide home dialysis services to skilled nursing facilities in Georgia.

 
 
 

Recent Posts

See All

Comments


bottom of page